On March 8, 2017, each of Mr. Luther C. Kissam, IV and Ms. Karen G. Narwold adopted a pre-arranged stock trading plan (each, the “Plan”) to exercise options with respect to up to 50,000 and 20,000 shares, respectively, and to sell the underlying stock. Options may not be exercised nor stock sold under either Plan until the completion of our previously announced plan to repurchase up to $250 million of our outstanding stock. Each Plan expires in the first quarter of 2018, unless earlier terminated.

The transactions under each Plan will be disclosed publicly through Form 144 and Form 4 filings with the Securities and Exchange Commission, as applicable. Each Plan was adopted in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, and the Company’s internal policies regarding stock transactions. In accordance with Rule 10b5-1, neither Mr. Kissam nor Ms. Narwold will have discretion over sales under their Plan.

The Company does not undertake to report Rule 10b5-1 plans that may be adopted by any of its officers or directors in the future, or to report any modifications or termination of any publicly announced trading plan, except to the extent required by law.

The information in this Item 7.01 is furnished to Item 7.01 of Form 8-K and is not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. The information contained herein is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

About ALBEMARLE CORPORATION (NYSE:ALB)

Albemarle Corporation is a developer, manufacturer and marketer of specialty chemicals across a range of end markets, including the petroleum refining, consumer electronics, energy storage, construction, automotive, steel and aerospace, lubricants, pharmaceuticals, crop protection, household appliances, heating, ventilation, aluminum finishing, food safety and custom chemistry services. The Company operates through the segments, including Performance Chemicals and Refining Solutions. The Company’s Performance Chemicals segment consists of product categories, including Lithium, Performance Catalyst Solutions and Bromine. The Company’s Lithium business develops advanced materials for a range of industries and end markets. The Company’s main product lines in the Refining Solutions segment are Clean Fuels Technologies, which is composed of hydroprocessing catalysts (HPC), and Heavy Oil Upgrading (HOU), which is composed of fluidized catalytic cracking (FCC) catalysts and additives.

ALBEMARLE CORPORATION (NYSE:ALB) Recent Trading Information

ALBEMARLE CORPORATION (NYSE:ALB) closed its last trading session down -1.05 at 102.74 with 1,285,087 shares trading hands.